Search research articles
Contact Us
Filters
Showing results (131-140 of 182) with videos related to
Page
of 19
Sort By:
Cancer
|
June 8, 2012
Safety, pharmacokinetics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignancies
Razelle Kurzrock, Sanjay Goel, Jennifer Wheler, et al.
Clinical Colorectal Cancer
|
April 17, 2017
Comparative Effectiveness Research: The Impact of Biologic Agents in Ethnic Minorities With Metastatic Colorectal Cancer
Sanjay Goel, Abdissa Negassa, Ashish Khot, et al.
NPJ Precision Oncology
|
January 20, 2026
Evaluation of immuno-oncologic biomarkers and β-catenin expression in response of hepatocellular carcinomas to immunotherapy
Gaurav Sharma, Yasmine Baca, Sanjay Goel, et al.
Clinical Colorectal Cancer
|
March 22, 2021
B7-H3 and PD-L1 Expression Are Prognostic Biomarkers in a Multi-racial Cohort of Patients with Colorectal Cancer
Wei Zhang, Ana Acuna-Villaorduna, Kevin Kuan, et al.
Research Square
|
January 18, 2024
Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancer
Midhun Malla, Sachin Kumar Deshkmukh, Sharon Wu, et al.
Investigational New Drugs
|
August 3, 2024
A phase I safety and efficacy clinical trial of plocabulin and gemcitabine in patients with advanced solid tumors
Mohammad H Ghalib, Mariano Provencio Pulla, Maria J De Miguel Luken, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
August 13, 2011
Intestinal epithelial-specific PTEN inactivation results in tumor formation
Do-Sun Byun, Naseem Ahmed, Shannon Nasser, et al.
Cell Biochemistry and Biophysics
|
April 11, 2007
Characterization of protein transacetylase from human placenta as a signaling molecule calreticulin using polyphenolic peracetates as the acetyl group donors
Seema, Ranju Kumari, Garima Gupta, et al.
Cancer Research
|
March 15, 2008
PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab
Minaxi Jhawer, Sanjay Goel, Andrew J Wilson, et al.
JCO Precision Oncology
|
August 5, 2024
Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers
Thejus Jayakrishnan, Yasmine Baca, Joanne Xiu, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 182) with videos related to
Sort By:
Page
of 19
Cancer
|
June 8, 2012
Safety, pharmacokinetics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignancies
Razelle Kurzrock, Sanjay Goel, Jennifer Wheler, et al.
Clinical Colorectal Cancer
|
April 17, 2017
Comparative Effectiveness Research: The Impact of Biologic Agents in Ethnic Minorities With Metastatic Colorectal Cancer
Sanjay Goel, Abdissa Negassa, Ashish Khot, et al.
NPJ Precision Oncology
|
January 20, 2026
Evaluation of immuno-oncologic biomarkers and β-catenin expression in response of hepatocellular carcinomas to immunotherapy
Gaurav Sharma, Yasmine Baca, Sanjay Goel, et al.
Clinical Colorectal Cancer
|
March 22, 2021
B7-H3 and PD-L1 Expression Are Prognostic Biomarkers in a Multi-racial Cohort of Patients with Colorectal Cancer
Wei Zhang, Ana Acuna-Villaorduna, Kevin Kuan, et al.
Research Square
|
January 18, 2024
Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancer
Midhun Malla, Sachin Kumar Deshkmukh, Sharon Wu, et al.
Investigational New Drugs
|
August 3, 2024
A phase I safety and efficacy clinical trial of plocabulin and gemcitabine in patients with advanced solid tumors
Mohammad H Ghalib, Mariano Provencio Pulla, Maria J De Miguel Luken, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
August 13, 2011
Intestinal epithelial-specific PTEN inactivation results in tumor formation
Do-Sun Byun, Naseem Ahmed, Shannon Nasser, et al.
Cell Biochemistry and Biophysics
|
April 11, 2007
Characterization of protein transacetylase from human placenta as a signaling molecule calreticulin using polyphenolic peracetates as the acetyl group donors
Seema, Ranju Kumari, Garima Gupta, et al.
Cancer Research
|
March 15, 2008
PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab
Minaxi Jhawer, Sanjay Goel, Andrew J Wilson, et al.
JCO Precision Oncology
|
August 5, 2024
Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers
Thejus Jayakrishnan, Yasmine Baca, Joanne Xiu, et al.
Page
of 19